BlackRock Health Sciences Term Trust (NYSE:BMEZ) Stock Price Down 1.2% – Time to Sell?

by · The Cerbat Gem

BlackRock Health Sciences Term Trust (NYSE:BMEZ – Get Free Report) was down 1.2% during trading on Thursday . The stock traded as low as $16.50 and last traded at $16.5420. 103,693 shares changed hands during mid-day trading, a decline of 51% from the average daily volume of 210,301 shares. The stock had previously closed at $16.75.

BlackRock Health Sciences Term Trust Trading Down 0.5%

The stock has a fifty day simple moving average of $16.07 and a two-hundred day simple moving average of $15.00.

BlackRock Health Sciences Term Trust Announces Dividend

The company also recently disclosed a monthly dividend, which will be paid on Tuesday, December 22nd. Investors of record on Friday, December 11th will be paid a dividend of $0.11 per share. The ex-dividend date of this dividend is Friday, December 11th. This represents a c) annualized dividend and a yield of 8.0%.

Institutional Trading of BlackRock Health Sciences Term Trust

Several institutional investors and hedge funds have recently bought and sold shares of the company. Saba Capital Management L.P. bought a new position in BlackRock Health Sciences Term Trust in the 1st quarter worth about $10,907,000. Rivernorth Capital Management LLC boosted its position in shares of BlackRock Health Sciences Term Trust by 195.8% during the 4th quarter. Rivernorth Capital Management LLC now owns 648,567 shares of the company’s stock valued at $9,761,000 after acquiring an additional 429,291 shares during the last quarter. Lazard Asset Management LLC bought a new stake in shares of BlackRock Health Sciences Term Trust during the 4th quarter valued at about $5,697,000. Invesco Ltd. grew its holdings in shares of BlackRock Health Sciences Term Trust by 42.7% during the third quarter. Invesco Ltd. now owns 929,121 shares of the company’s stock worth $13,398,000 after purchasing an additional 278,024 shares in the last quarter. Finally, Almitas Capital LLC purchased a new position in shares of BlackRock Health Sciences Term Trust during the fourth quarter worth about $2,301,000.

BlackRock Health Sciences Term Trust Company Profile

(Get Free Report)

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.

Featured Articles